Brain Health

Armodafinil and modafinil have wake-promoting actions similar to sympathomimetic agents.

New study results show that of those who tested or were presumed positive for SARS-CoV-2, 44% developed neurological symptoms.

The results of a new analysis show that just 12 to 14 doses of stimulation for the body and mind may be all that is needed to boost brain function.

Tau protein, plaque, and brain waves maybe the solutions to treating the progressive condition.

New study results may help improve automated methods for detecting these spindles and correlating them with brain function, investigators say.

Daridorexant (Quviviq) is indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance.

New study results suggest that severe depression and sexual dysfunction, in particular, can affect a woman's attention, language, orientation, recall, registration, and visuospatial skills.

Analysis examines the impacted of expected trends in exposure to high blood sugar, low education levels, obesity, and smoking.

Daridorexant (Quviviq, Idorsia Pharmaceuticals) is indicated for adults who experience difficulties with sleep onset and/or sleep maintenance.

New study results show that though men are more likely to have heart conditions, the impact on their memory and thinking skills is lower.

There were no instances of participants withdrawing from the study due to an adverse event caused by psilocybin in the treatment of mental health conditions.

When using a therapy to clear the senescent cells, disease progression and cell death were stopped, according to the study.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses the problems with approaching public health issues, such as mental health and substance use disorders, with an industrialized approach to problem solving.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses whether the adoption and acknowledgement of psychedelic medicine in health care systems looks likely for the future.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which environments each psychedelic medicine is likely to be administered.

Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which psychedelic drugs are currently under investigation for potential FDA approval.

Study indicates those who experienced a greater amount of stress from the COVID-19 pandemic had reduced information processing speed.

Investigators found that an additional hour of sleep correlated with a 26% decrease in an infant’s risk of being overweight.

Study results show that clonal hematopoiesis of indeterminate potential is associated with a lower likelihood of developing AD.

Although the test does not definitively diagnose problems such as Alzheimer disease, it helps physicians get a baseline of their patients’ cognitive functioning.

Study results show more activity in brain areas affecting sympathy and movement when the women viewed the photos.

Investigators focus on the relationship with neuron activity and find that sodium consumption plays a role.

The technique uses light and nanoparticles to temporarily open the tight junctions that protect the brain and allow medication to reach its target.

An embryonic stem cell model allowed investigators to study the genetic architecture first in hypothalamic progenitor cells, prior to their full development, and then nucleus-like hypothalamic neurons.